"TAM" commonly refers to Tumor-Associated Macrophages in oncology literature or the Tyro3, Axl, MerTK (TAM) receptor family in immunology and cancer research .
The number "14" could denote a specific isoform, clone, or target (e.g., TAS2R14, a taste receptor) , but no "tam14" antibody is documented in the sources.
Several antibodies targeting TAM receptors (Tyro3, Axl, MerTK) are under investigation for cancer therapy :
| Antibody Name | Target | Application | Clinical Stage |
|---|---|---|---|
| DAXL-88 | Axl | Inhibits tumor growth in NSCLC | Preclinical trials |
| MAb173 | MerTK | Reduces metastasis in breast cancer | Phase I/II |
| YW327.6S2 | Tyro3 | Blocks GAS6 signaling in glioblastoma | Preclinical studies |
None are designated "tam14."
MN-14: A high-affinity anti-CEA antibody tested in clinical trials for tumor targeting .
Anti-14-3-3 zeta: An autoantibody linked to liver cancer prediction .
The absence of "tam14" highlights broader issues in antibody specificity and reproducibility:
Commercial antibodies often lack rigorous validation, leading to misidentification of targets (e.g., angiotensin receptors) .
Initiatives like NeuroMab and YCharOS emphasize standardized characterization to address these gaps .
Verify nomenclature: Confirm whether "tam14" refers to a macrophage subtype (TAMs), receptor isoform, or unpublished reagent.
Explore related targets: Investigate antibodies against TAM receptors or biomarkers like 14-3-3 zeta .
Consult specialized databases: Use resources like the DSHB (Developmental Studies Hybridoma Bank) or Addgene for recombinant antibodies .
KEGG: spo:SPCC330.20
STRING: 4896.SPCC330.20.1
Tam14 (Uniprot accession: G2TRT3) is a protein expressed in Schizosaccharomyces pombe (strain 972 / ATCC 24843), commonly known as fission yeast . S. pombe has emerged as a powerful tractable system for studying DNA damage repair mechanisms, with high conservation in chromosome structure and function genes compared to humans . While specific tam14 function is not fully characterized in the provided materials, antibodies against S. pombe proteins like tam14 are valuable tools for investigating cellular processes in this model organism.
Based on similar research-grade antibodies, tam14 antibodies are primarily used for Western blotting applications in S. pombe research . They enable detection of native tam14 protein expression, localization studies via immunofluorescence, and potential protein-protein interaction analyses through immunoprecipitation techniques. These applications are essential for researchers investigating fission yeast cellular mechanisms.
While specific dilution recommendations for tam14 antibody are not provided in the search results, comparable research antibodies for S. pombe proteins typically utilize dilution ratios between 1:500 to 1:1000 for Western blot applications . Researchers should perform optimization experiments to determine the ideal concentration that maximizes specific signal while minimizing background for their specific experimental conditions.
When designing experiments with tam14 antibody, researchers should incorporate the following controls:
Positive control: Wild-type S. pombe lysate with known tam14 expression
Negative control: Either a tam14 deletion strain or pre-immune serum
Loading control: Detection of a constitutively expressed S. pombe protein (e.g., tubulin)
Specificity control: Pre-adsorption of antibody with immunizing peptide
These controls ensure experimental validity by confirming antibody specificity and proper experimental execution .
For optimal detection of tam14 in S. pombe, researchers should consider the following lysate preparation protocol:
Harvest cells during logarithmic growth phase
Disrupt cell walls using glass beads in appropriate lysis buffer
Include protease inhibitors to prevent protein degradation
Clear lysate by centrifugation (typically 14,000 × g for 10 minutes)
Quantify protein concentration prior to gel loading
This approach preserves protein integrity while maximizing extraction efficiency from the rigid fission yeast cell wall .
Validating antibody specificity is critical for experimental rigor. Recommended validation approaches include:
Comparing signal between wild-type and tam14 deletion/knockdown strains
Using multiple antibodies targeting different tam14 epitopes
Performing peptide competition assays
Correlating protein detection with mRNA expression levels
Confirming expected molecular weight (comparing observed vs. predicted band size)
High background is a common challenge when using antibodies in S. pombe research. To reduce background:
Increase blocking agent concentration (5% BSA or milk)
Optimize primary antibody concentration through titration experiments
Increase washing duration and frequency (4-5 washes of 10 minutes each)
Add 0.1-0.5% Tween-20 to washing buffer
Consider using alternative blocking reagents (commercial blockers designed for yeast applications)
Pre-adsorb the antibody with total protein from a tam14 deletion strain
These approaches specifically address the challenges of detecting low-abundance proteins like tam14 against complex cellular backgrounds .
For successful immunoprecipitation of tam14 in S. pombe:
Use gentle lysis conditions to preserve protein-protein interactions
Pre-clear lysates with protein A/G beads to reduce non-specific binding
Optimize antibody:lysate ratio through titration experiments
Include appropriate controls (IgG control, input sample)
Consider crosslinking antibody to beads to prevent antibody contamination
Validate results with reverse co-immunoprecipitation when studying interactions
These adjustments account for the unique challenges of working with yeast proteins while maximizing specific signal recovery .
Optimal fixation for S. pombe immunofluorescence with tam14 antibody likely includes:
Methanol fixation (-20°C, 6 minutes) for nuclear proteins
Formaldehyde fixation (3.7%, 30 minutes) followed by cell wall digestion for cytoplasmic proteins
Combined formaldehyde/glutaraldehyde (3.7%/0.2%) for preserving fine structural details
The choice depends on tam14's subcellular localization and epitope sensitivity to different fixatives. Pilot experiments comparing methods are recommended for optimization .
For studying tam14 involvement in mitotic recombination:
Design time-course experiments following DNA damage induction
Combine ChIP (chromatin immunoprecipitation) with tam14 antibody to identify DNA binding sites
Use FRAP (fluorescence recovery after photobleaching) with fluorescently-tagged tam14 to measure protein mobility
Implement proximity ligation assays to detect protein-protein interactions during recombination
Perform immunoprecipitation followed by mass spectrometry to identify interacting partners
These approaches provide insights into tam14's potential role in DNA damage response pathways that are highly conserved between yeast and humans .
When incorporating tam14 antibody in chromosome loss studies:
Design experiments using established S. pombe minichromosome systems (e.g., Ch16 derivatives)
Consider tam14's potential role in chromosome stability based on localization patterns
Implement pulse-field gel electrophoresis (PFGE) to distinguish between true chromosome loss and gene conversion events
Use appropriate genetic backgrounds (e.g., DNA repair mutants) to enhance phenotypic effects
Correlate antibody-detected protein levels with observed chromosome loss frequencies
These approaches align with established methodologies for studying chromosome dynamics in fission yeast .
For quantitative assessment of tam14 expression throughout the cell cycle:
Synchronize S. pombe cultures using established methods (nitrogen starvation, temperature-sensitive cdc mutants)
Collect samples at defined time points covering the complete cell cycle
Perform Western blotting with tam14 antibody alongside cell cycle markers
Implement quantitative immunofluorescence microscopy with co-staining for cell cycle stage markers
Use flow cytometry for correlating tam14 levels with DNA content
This multimodal approach provides comprehensive insights into potential cell cycle-dependent regulation of tam14 .
Cross-species applicability requires careful consideration:
Perform sequence homology analysis between tam14 and potential homologs in target species
Consider epitope conservation if the immunizing peptide sequence is known
Validate with positive controls from target species alongside S. pombe samples
Test multiple antibody concentrations in pilot experiments
Include appropriate negative controls (knockouts/knockdowns in target species)
While cross-reactivity cannot be guaranteed without experimental validation, high sequence conservation may enable detection in closely related species .
Translating findings between S. pombe and human systems requires:
Identifying human homologs through bioinformatic approaches
Verifying functional conservation through complementation studies
Comparing localization patterns between organisms
Evaluating conservation of interaction partners and regulatory mechanisms
Validating key findings in human cell lines with antibodies against the human homolog
S. pombe has proven valuable for studying conserved cellular mechanisms due to its significant homology with human genes involved in chromosome structure and function .
For robust statistical analysis of tam14 antibody data:
Perform at least three biological replicates for quantitative experiments
Apply appropriate normalization to account for loading variations
Use parametric tests (t-test, ANOVA) when normality assumptions are met
Consider non-parametric alternatives when distributions are non-normal
Calculate effect sizes in addition to p-values
Implement multiple comparison corrections when analyzing numerous conditions
These approaches ensure reliable interpretation of experimental results and minimize false discoveries .
When facing discrepancies between antibody detection and genetic approaches:
Verify antibody specificity through additional validation experiments
Consider post-translational modifications that might affect antibody recognition
Evaluate potential genetic compensation mechanisms in knockout/knockdown studies
Assess whether timing differences might explain the contradictions
Implement orthogonal techniques (mass spectrometry, RNA-seq) for independent verification
Consider whether the antibody epitope might be masked in certain protein complexes or conformations
This systematic approach helps resolve apparent contradictions and often leads to new biological insights .
For optimal antibody performance:
Store undiluted antibody at -20°C for long-term storage
Avoid repeated freeze-thaw cycles by preparing single-use aliquots
Store working dilutions at 4°C for up to two weeks
Include preservatives (0.02% sodium azide) for extended 4°C storage
Centrifuge briefly before use to collect solution at the bottom of the tube
Avoid prolonged exposure to light, especially for conjugated antibodies
These practices maximize antibody shelf-life and experimental reproducibility .
Optimal detection systems include:
Enhanced chemiluminescence (ECL) for standard applications
Fluorescently-labeled secondary antibodies for multiplexing capabilities
Infrared detection systems for superior quantitative linearity
Tyramide signal amplification for detecting low-abundance tam14 expression
Quantum dot-conjugated secondaries for enhanced sensitivity and stability
The choice should be guided by specific experimental needs, particularly considering tam14's abundance in your experimental system .
CRISPR/Cas9 approaches offer several advantages:
Creation of precise tam14 knockouts as definitive negative controls
Generation of epitope-tagged tam14 variants for antibody validation
Introduction of point mutations to study structure-function relationships
Development of reporter systems for monitoring tam14 expression in vivo
Creation of conditional expression systems for temporal control
These genetic tools complement antibody-based approaches and enable more sophisticated experimental designs .
Cutting-edge technologies applicable to tam14 research include:
Super-resolution microscopy for detailed localization studies
Proximity labeling (BioID, APEX) for identifying interaction networks
Single-cell Western blotting for analyzing cell-to-cell variability
Automated high-content imaging for phenotypic profiling
Microfluidic approaches for real-time protein dynamics studies
Cryo-electron microscopy for structural analysis of tam14-containing complexes
These approaches extend traditional antibody applications into new research domains with enhanced resolution and throughput .